Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 13, 2007

Primary Completion Date

July 17, 2008

Study Completion Date

July 17, 2008

Conditions
Parkinson's Disease
Interventions
DRUG

piclozotan

piclozotan, intravenous (IV) infusion

DRUG

0.9% sodium chloride (normal saline)

0.9% sodium chloride (normal saline) intravenous (IV) infusion

Trial Locations (7)

11203

Suny Downstate Medical Center, Brooklyn

30329

Emory University--Wesley Woods Health Center, Atlanta

33606

University of South Florida, Parkinson's Disease and Movement Disorders Center, Tampa

92708

The Parkinson's and Movement Disorder Institute, Fountain Valley

08901

UMDNJ-Robert Wood Johnson Medical School, New Brunswick

Unknown

Hospital Multimedica, Guatemala City

Hospital Clinic of Neurology and Psychiatry Oradea, Oradea

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY